481 results on '"Seinen W"'
Search Results
2. Letter to Editor, International Journal of Pharmaceutics
3. Microdosing of a Carbon-14 Labeled Protein in Healthy Volunteers Accurately Predicts Its Pharmacokinetics at Therapeutic Dosages
4. An integral feasibility study of a new weir in the Lower Rhine
5. High Level Expression of Tissue-Nonspecific Alkaline Phosphatase in the Milk of Transgenic Rabbits
6. Characterization of CYP1A in hepatocytes of cynomolgus monkeys (Macaca fascicularis) and induction by different substituted polychlorinated biphenyls (PCBs)
7. Nachtwerk en borstkanker
8. Differential effects of organotin compounds on voltage-gated potassium currents in lymphocytes and neuroblastoma cells
9. Uptake of hydrophobic halogenated aromatic hydrocarbons from food by earthworms (Eisenia andrei)
10. Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).
11. Physiologically Based Pharmacokinetic Model for Tetrachlorobenzyltoluenes in Rat: Comparison of in Vitro and in Vivo Metabolic Rates
12. Effect of Organotin Compounds on Lymphoid Organs and Lymphoid Functions: An Overview
13. The autoimmunogenic chemicals HgCl2 and diphenylhydantoin stimulate IgG production to TNP-Ficoll and TNP-OVA, supporting and extending the graft-versus-host hypothesis for chemical induction of autoimmunity
14. Immunotoxicity of Organotin Compounds. A Cell Biological Approach to Dialkyltin Induced Thymus Atrophy
15. An Immunohistochemical Study of Dibutyltin-Induced Thymus Atrophy
16. Effects of Ammonia Caramel and Tetrahydroxybutylimidazole on the Immune System of Rats
17. Thymus Atrophy and Immunosuppression Induced by Organotin Compounds
18. Immunosuppression induced by certain organotin compounds
19. Kinetics and morphology of chemically induced popliteal lymph node reactions compared with antigen-, mitogen-, and graft-versus-host-reaction-induced responses
20. The toxicokinetic behavior of chlorobenzenes in earthworm (Eisenia andrei) experiments in soil
21. Prophylactic treatment with alkaline phosphatase in cardiac surgery induces endogenous alkaline phosphatase release.
22. Safety and efficacy of Danisco Xylanase G/L (endo-1,4-beta-xylanase) as a feed additive for chickens for fattening, laying hens and ducks for fattening. Scientific Opinion of the Panel on Additives and Products or Substances used in Animal Feed and of the Panel on Genetically Modified Organisms:(Question No EFSA-Q-2006-137)
23. Statement of the Scientific Panel on Genetically Modified Organisms on the safe use of the nptII antibiotic resistance marker gene in genetically modified plants
24. Opinion of the Scientific Panel on Genetically Modified Organisms on an application (Reference EFSA-GMO-NL-2005-18) for the placing on the market of the glufosinate tolerant soybean A2704-12, for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Bayer CropScience:(Question No EFSA-Q-2005-174)
25. Opinion of the Scientific Panel on genetically Modified Organisms on an application (Reference EFSA-GMO-NL-2005-12) for the placing on the market of insect-resistant genetically modified maize 59122, for food and feed uses, import and processing under Regulation (EC) No 1829/2003, from Pioneer Hi-Bred International, Inc. and Mycogen Seeds, c/o Dow Agrosciences LLC:(Question No EFSA-Q-2005-045)
26. Opinion of the Scientific Panel on Additives and Products or Substances used in Animal Feed and the Scientific Panel on genetically Modified Organisms on the safety and efficacy of the enzyme preparation Rovabio TM PHY AP/LC (3-phytase) as feed additive for chickens for fattening, laying hens, piglets and pigs for fattening in accordance with Regulation (EC) No 1831/2003:(Question No EFSA-Q-2005-281)
27. Thymocytes as Target of Dialkyltin Toxicity
28. The Lymphocyte as Target of Toxicity: a Biochemical Approach to Dialkyltin Induced Immunosuppression
29. The Popliteal Lymph Node Assay: A Test System for Chemically Induced Autoimmune and Allergic Reactions
30. Cyclization Products of Phenylthiourea Compounds in Adulterated Rapeseed Oil as possible Aetiological Factor in Spanish Toxic Oil Syndrome
31. Opinion of the Scientific Panel on Genetically Modified Organisms on an application (Reference EFSA-GMO-NL-2005-13) for the placing on the market of glufosinate-tolerant genetically modified LLCotton25, for food and feed uses, and import and processing under Regulation (EC) No 1829/2003 from Bayer CropScience:(Question No EFSA-Q-2005-047)
32. Opinion of the Scientific Panel on Genetically Modified Organisms on an application (Reference EFSA-GMO-UK-2004-08) for the placing on the market of products produced from glyphosate-tolerant genetically modified sugar beet H7-1, for food and feed uses, under Regulation (EC) No 1829/2003 from KWS SAAT AG and Monsanto. (Question No EFSA-Q-2004-164)
33. Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the notification (Reference C/SE/96/3501) for the placing on the market of genetically modfied potato EH92-527-1 with altered starch composition, for cultivation and production of starch, under Part C of Directive 2001/18/EC from BASF Plant Science:(Question No EFSA-Q-2005-023)
34. Opinion of the Scientific Panel on Genetically Modified Organisms on the Post Market Environmental Monitoring (PMEM) of genetically modified plants:(Question No EFSA-Q-2004-061)
35. Guidance document of the Scientific Panel on Genetically Modified Organisms for renewal of authorisations of existing GMO products lawfully placed on the market, notified according to Articles 8 and 20 of regulation (EC) No 1829/2003. (Question No EFSA-Q-2003-005C)
36. Guidance document of the Scientific Panel on genetically modified organisms for the risk assessment of genetically modified plants and derived food and feed. (Question no EFSA-Q-2003-005)
37. Open Source Software vanuit internationaal privaatrechtelijk perspectief
38. Guidance document of the Scientific Panel on Genetically Modified Organisms for renewal of authorisations of existing GMO products lawfully placed on the market, notified according to Articles 8 and 20 of Regulation (EC) No 1829/2003
39. Gezondheidseffectscreening Moerdijkse Hoek. Vierde advies van de Wetenschappelijke Toetsingscommissie Gezondheid-effectscreening Moerdijkse Hoek
40. Gezondheidseffectscreening Moerdijkse Hoek. Derde advies van de Wetenschappelijke Toetsingscommissie Gezondheid-effectscreening Moerdijkse Hoek
41. Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the safeguard clause invoked by Hungary according to Article 23 of Directive 2001/18/EC (Question No EFSA-Q-2005-055)
42. Opinion of the Scientific Panel on Genetically Modified Organisms on an application (Reference EFSA-GMO-BE-2004-07) for the placing on the market of insect-protected glyphosate-tolerant genetically modified maize MON863 X MON 810 X NK603, for food and feed uses, and import and processing under Regulation (EC) No 1829/2003 from Mosanto (Question No EFSA-Q-2004-159)
43. Opinion of the Scientific Panel on Genetically Modified Organisms on an application (Reference EFSA-GMO-UK-2004-06) for the placing on the market of insect-protected glyphosate-tolerant genetically modified maize MON863 X NK603, for food and feed uses, and import and processing under Regulation (EC) No 1829/2003 from Monsanto (Question No EFSA-Q-2004-154)
44. Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the notification (Reference C/ES/01/01) for the placing on the market of insect-tolerant genetically modified maize 1507 for import, feed and industrial processing and cultivation, under Part C of Directive 2001/18/EC from Pioneer Hi-Bred International/Mycogen Seeds (Question No EFSA-Q-2004-072)
45. Introduction of ethoxy-resorufin-o-deethylase activity by halogenated aromatic hydrocarbons and polycyclic aromatic hydrocarbons in primary hepatocytes of the green frog (Rana esculenta)
46. Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the Notification (Reference C/DE/02/9) for the placing on the market of insect-protected genetically modified maize MON 863 X MON 810, for import and processing, under Part C of Directive 2001/18/EC from Monsanto (Question No EFSA-Q-2003-089)
47. CP-arene oxides: the ultimate, active mutagenic forms of cyclopenta-fused polycyclic aromatic hydrocarbons (CP-PAHs)
48. Opinion of the Scientific Panel on Genetically Modified Organisms on an application (Reference EFSA-GMO-DE-2004-03) for the placing on the market of insect-protected genetically modified maize MON 863 X MON 810, for food and feed use, under Regulation (EC) No 1829/2003 from Monsanto (Question No EFSA-Q-2004-112)
49. Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the notification (Reference C/F/96/05.10) for the placing on the market of insect resistant genetically modified maize Bt11, for cultivation, feed and industrial processing, under Part C of Directive 2001/18/EC from Syngenta Seeds (Question No EFSA-Q-2004-012)
50. Opinion of the Scientific Panel on Genetically Modified Organisms on an application (reference EFSA-GMO-NL-2004-02) for the placing on the market of insect-tolerant genetically modified maize 1507, for food use, under Regulation (EC) No 1829/2003 from Pioneer Hi-Bred International/Mycogen Seeds (Question no EFSA-Q-2004-087)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.